BiVACOR, the US-based company behind the world’s first rotary artificial heart, has located its international office in the Gold Coast Health and Knowledge Precinct, where it will conduct final blood compatibility R&D with the world-class Griffith University Mechanobiology Research lab.
BiVACOR hopes to implant its revolutionary artificial heart device into the first patients within 2-5 years. Here CEO Daniel Timms talks about the technology and the Gold Coast advantage.